NIMOTOP (Nimotop 30 MG)
Generic Name: nimodipine
Pill imprint NIMOTOP has been identified as Nimotop 30 MG.
Nimotop is used in the treatment of subarachnoid hemorrhage and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimotop 30 MG is not subject to the Controlled Substances Act.
See also related documents.
Images for NIMOTOP (Nimotop 30 MG)
- Generic Name:
- nimodipine
- Imprint:
-
NIMOTOP
- Strength:
- 30 MG
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00026-2855
| NDC Code | Manufacturer / Repackager |
|---|---|
| 50419-0855 | Bayer Healthcare Pharmaceuticals |
Note: Inactive ingredients may vary.
More resources
Nimotop is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

